2026年3月20日 / 美国东部时间下午2:54 / CBS新闻
根据美国食品药品监督管理局发布的通知，近9万瓶儿童布洛芬因可能含有异物正在被召回。
此次召回涉及儿童布洛芬口服混悬液，这是一种液态止痛药。该产品由印度Strides Pharma公司为Taro Pharmaceuticals生产。
根据Taro公司网站上的产品说明，这种药物适用于2至11岁的儿童，可帮助减轻疼痛和发烧，液态布洛芬有浆果口味。
Strides Pharma公司在收到投诉称瓶子内含有”凝胶状物质和黑色颗粒”后，于3月2日启动了此次召回。美国食品药品监督管理局在通知中表示，该药物已在全美范围内分销。
美国食品药品监督管理局将此次召回归类为二级召回，根据该机构网站的说明，二级召回是指接触产品可能造成”暂时性或医学上可逆转的不良健康后果”。
该产品的召回编号为D-0390-2026。
Nearly 90,000 bottles of children’s ibuprofen recalled due to reports of foreign substances
March 20, 2026 / 2:54 PM EDT / CBS News
Nearly 90,000 bottles of children’s ibuprofen are being recalled because they may contain a foreign substance, according to a notice issued by the U.S. Food and Drug Administration.
The recall affects Children’s Ibuprofen Oral Suspension, a pain reliever that comes in liquid form. The product was manufactured in India by Strides Pharma for Taro Pharmaceuticals.
The medication is intended for children ages 2 to 11 and helps reduce pain and fever, according to a description of the product on Taro’s website. The liquid ibuprofen comes in a berry flavor.
Strides Pharma initiated the recall on March 2 after receiving complaints that the bottles contained”a gel-like mass and black particles.” The medication was distributed nationwide, the FDA said in its notice.
The FDA classified this as a Class II recall, which is when exposure to a product can create “temporary or medically reversible adverse health consequences,” according to the agency’s website.
The recall number for the product is D-0390-2026.
发表回复